Chemiesynth(Vapi

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE829R01018
  • NSEID:
  • BSEID: 539230
INR
48.00
0.00 (0.00%)
BSENSE

Mar 30

BSE+NSE Vol: 10

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

10 (233.33%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

62.35%

When is the next results date for Chemiesynth(Vapi?

06-Jun-2025

No Upcoming Board Meetings

how big is Chemiesynth(Vapi?

06-Jun-2025

As of May 06, Chemiesynth (Vapi) Ltd has a market capitalization of 10.00 Cr, classifying it as a Micro Cap company, with no valid financial data available for the latest four quarters. As of March 2024, the Shareholder's Funds are 11.34 Cr and Total Assets are 31.37 Cr.

Market Cap: As of May 06, Chemiesynth (Vapi) Ltd has a market capitalization of 10.00 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid Consolidated or Standalone financial data available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: This is Standalone data for the reporting period of March 2024. The Shareholder's Funds are reported at 11.34 Cr, and the Total Assets amount to 31.37 Cr.

View full answer

Who are the top shareholders of the Chemiesynth(Vapi?

06-Jun-2025

The top shareholders of Chemiesynth (Vapi) include promoter Satish Bhogilal Zaveri with 38.82%, and Upl Limited as the largest public shareholder at 30%. Individual investors hold 4.66%, with no pledged promoter holdings or mutual funds/foreign institutional investors involved.

The top shareholders of Chemiesynth (Vapi) include the promoters, with Satish Bhogilal Zaveri holding the largest share at 38.82%. Additionally, Upl Limited is the highest public shareholder, owning 30% of the company. Individual investors collectively hold 4.66% of the shares. Notably, there are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares.

View full answer

What does Chemiesynth(Vapi do?

06-Jun-2025

Chemiesynth (Vapi) Ltd is a custom manufacturer in specialty chemicals, focusing on agro chemicals and pharmaceuticals, with a market cap of Rs 10 Cr and reported net sales of 7 Cr for the quarter ending March 2025. The company has no net profit, dividend yield, or debt.

Overview:<BR>Chemiesynth (Vapi) Ltd is a custom manufacturer in the specialty chemicals industry, focusing on agro chemicals, pharmaceuticals, and other organic chemical synthesis.<BR><BR>History:<BR>Incorporated in April 1986, Chemiesynth (Vapi) Ltd has over 30 years of experience in the industry. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 7 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 10 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price to Book: 0.00<BR><BR>Contact Details:<BR>Address: 27 GIDC, 1st Phase VAPI Gujarat : 396195 <BR>Tel: 91-260-2432885 <BR>Email: corporate@chemiesynth.com <BR>Website: http://www.chemiesynth.com

View full answer

Has Chemiesynth(Vapi declared dividend?

06-Jun-2025

No Dividend History Available

What is the technical trend for Chemiesynth(Vapi?

09-Jun-2025

As of June 11, 2024, Chemiesynth (Vapi) shows a neutral technical trend with a stagnant price of 32.52 and no significant volatility or trading activity.

As of 11 June 2024, the technical trend for Chemiesynth (Vapi) has changed from mildly bullish to does not qualify. The current price is stagnant at 32.52, with no movement in the 52-week high or low, indicating a lack of volatility and trading activity. Given the absence of technical summary data and the unchanged price levels, the current technical stance is neutral, reflecting insufficient data to form a definitive view on strength or direction.

View full answer

Who are in the management team of Chemiesynth(Vapi?

16-Jul-2025

As of March 2022, the management team of Chemiesynth (Vapi) includes Satish Bhogilal Zaveri, Sandip Satishbhai Zaveri, Bhanurai Nagindas Mehta, Pramod Gopaldas Gujarathi, Rushabh Mehta, Pallavi Singh, and Jigna Prajapati, overseeing the company's strategic direction and governance.

As of March 2022, the management team of Chemiesynth (Vapi) includes the following individuals:<BR><BR>1. Satish Bhogilal Zaveri - Non-Executive & Non-Independent Director<BR>2. Sandip Satishbhai Zaveri - Managing Director<BR>3. Bhanurai Nagindas Mehta - Non-Executive & Non-Independent Director<BR>4. Pramod Gopaldas Gujarathi - Non-Executive & Independent Director<BR>5. Rushabh Mehta - Non-Executive & Non-Independent Director<BR>6. Pallavi Singh - Company Secretary & Compliance Officer<BR>7. Jigna Prajapati - Independent Director<BR><BR>This team is responsible for the strategic direction and governance of the company.

View full answer

How has been the historical performance of Chemiesynth(Vapi?

12-Aug-2025

Chemiesynth (Vapi) has shown mixed historical performance, with steady growth in shareholder's funds and total assets, but challenges in profitability and cash flow, reporting no profit before tax in the last two years. Total liabilities increased significantly, reflecting higher obligations alongside a decline in total reserves.

Answer:<BR>The historical performance of Chemiesynth (Vapi) shows a mixed trend over the years, particularly in its financial metrics.<BR><BR>Breakdown:<BR>Chemiesynth (Vapi) has maintained a consistent share capital of Rs 3.07 crore from March 2018 to March 2024. Total reserves peaked at Rs 8.66 crore in March 2023 but slightly declined to Rs 8.27 crore in March 2024. Shareholder's funds have shown a steady increase from Rs 2.41 crore in March 2018 to Rs 11.34 crore in March 2024. Long-term borrowings have increased from Rs 6.95 crore in March 2018 to Rs 8.56 crore in March 2024, with unsecured loans being the primary contributor. The total liabilities rose from Rs 11.90 crore in March 2018 to Rs 31.37 crore in March 2024, reflecting an overall growth in the company's obligations. Total assets also increased from Rs 11.90 crore in March 2018 to Rs 31.37 crore in March 2024, indicating a positive trend in asset accumulation. However, the company reported no profit before tax in the last two years, with a peak profit of Rs 4 crore in March 2021. Cash flow from operating activities has been inconsistent, with no cash inflow reported in the last two years, while cash flow from investing activities has been negative, indicating ongoing investments. Overall, the company's financial health shows growth in assets and liabilities, but challenges in profitability and cash flow management.

View full answer

Why is Chemiesynth (Vapi) Ltd falling/rising?

03-Apr-2026

As of 02-Apr, Chemiesynth (Vapi) Ltd's stock price is currently at Rs. 48.00, with no change from the previous close. The stock has shown strong performance with a 10.22% increase over the past week and a 21.49% increase over the past month, driven by heightened investor interest and positive technical indicators.

As of 02-Apr, Chemiesynth (Vapi) Ltd's stock price is currently at Rs. 48.00, with no change from the previous close. The stock has been experiencing a notable rise, evidenced by a 10.22% increase over the past week and a 21.49% increase over the past month. Year-to-date, the stock has risen by 27.56%, significantly outperforming the Sensex, which has declined by 13.96% during the same period.<BR><BR>Today, the stock reached a new 52-week and all-time high of Rs. 48, reflecting strong performance. It opened with a gain of 4.99% and has maintained this price throughout the trading session. The stock has shown consistent gains over the last two days, contributing to its upward momentum. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong bullish trend.<BR><BR>Investor participation has also increased, with delivery volume rising by 66.67% compared to the 5-day average, suggesting growing interest in the stock. Despite some erratic trading patterns, where the stock did not trade on three days out of the last twenty, the overall sentiment remains positive, contributing to the stock's rise. <BR><BR>In summary, Chemiesynth (Vapi) Ltd is rising due to strong recent performance, increased investor interest, and positive technical indicators.

View full answer

Which are the latest news on Chemiesynth(Vapi?

03-Apr-2026
No latest news for Chemiesynth(Vapi found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 14 Cr (Micro Cap)

stock-summary
P/E

stock-summary
Industry P/E

36

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
5 Cr
(Quarterly Results - Dec 2025)
Net Profit:
-1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
27.56%
0%
27.56%
6 Months
33.93%
0%
33.93%
1 Year
47.6%
0%
47.6%
2 Years
62.66%
0%
62.66%
3 Years
140.0%
0%
140.0%
4 Years
164.46%
0%
164.46%
5 Years
0%
0%
0.0%

Chemiesynth(Vapi for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Closure of Trading Window

25-Mar-2026 | Source : BSE

Pursuant to SEBI(PIT) Regulation 2015 the trading window for dealing in the equity shares of the company will be closed for all directors designated persons connected person and immediate relatives with effect from 01 st April 2026 till the expiry of 48 hours after declaration of Audited Financial Results of the company for the quarter and year ending 31st March 2026

Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

25-Mar-2026 | Source : BSE

Disclosure under regulation 30 of SEBI (LODR) Regulation 2015 -appointment of Internal Auditor for the financial year 2025-26 & 2026-27

Board Meeting Outcome for Outcome Of Board Meeting

25-Mar-2026 | Source : BSE

Appointment of Internal Auditor for the Financial Year 2025-26 & 2026-27.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

No Data Found

Valuation key factors

No Data Found

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
Moving Averages
Bullish (Daily)
KST
Dow Theory
Bullish
Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Satish Bhogilal Zaveri (38.82%)

Highest Public shareholder

Upl Limited (30%)

Individual Investors Holdings

4.66%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -25.91% vs 73.05% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -59.09% vs 4.35% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.09",
          "val2": "6.87",
          "chgp": "-25.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.06",
          "val2": "0.18",
          "chgp": "-133.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.27",
          "chgp": "-3.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.70",
          "val2": "-0.44",
          "chgp": "-59.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.18%",
          "val2": "2.62%",
          "chgp": "-3.80%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 30.41% vs -5.02% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -629.41% vs -50.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.85",
          "val2": "8.32",
          "chgp": "30.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.37",
          "val2": "1.15",
          "chgp": "-67.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.52",
          "val2": "0.25",
          "chgp": "108.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.90",
          "val2": "0.17",
          "chgp": "-629.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.41%",
          "val2": "13.82%",
          "chgp": "-10.41%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 30.66% vs 1.84% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -433.33% vs -66.67% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15.94",
          "val2": "12.20",
          "chgp": "30.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.31",
          "val2": "1.38",
          "chgp": "-77.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.78",
          "val2": "0.59",
          "chgp": "32.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.60",
          "val2": "-0.30",
          "chgp": "-433.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.94%",
          "val2": "11.31%",
          "chgp": "-9.37%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 14.97% vs -21.54% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 71.79% vs -169.64% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.89",
          "val2": "16.43",
          "chgp": "14.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.18",
          "val2": "1.53",
          "chgp": "42.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.70",
          "chgp": "14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.11",
          "val2": "-0.39",
          "chgp": "71.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.54%",
          "val2": "9.31%",
          "chgp": "2.23%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
5.09
6.87
-25.91%
Operating Profit (PBDIT) excl Other Income
-0.06
0.18
-133.33%
Interest
0.26
0.27
-3.70%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.70
-0.44
-59.09%
Operating Profit Margin (Excl OI)
-1.18%
2.62%
-3.80%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -25.91% vs 73.05% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -59.09% vs 4.35% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
10.85
8.32
30.41%
Operating Profit (PBDIT) excl Other Income
0.37
1.15
-67.83%
Interest
0.52
0.25
108.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.90
0.17
-629.41%
Operating Profit Margin (Excl OI)
3.41%
13.82%
-10.41%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 30.41% vs -5.02% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -629.41% vs -50.00% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
15.94
12.20
30.66%
Operating Profit (PBDIT) excl Other Income
0.31
1.38
-77.54%
Interest
0.78
0.59
32.20%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.60
-0.30
-433.33%
Operating Profit Margin (Excl OI)
1.94%
11.31%
-9.37%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 30.66% vs 1.84% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -433.33% vs -66.67% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
18.89
16.43
14.97%
Operating Profit (PBDIT) excl Other Income
2.18
1.53
42.48%
Interest
0.80
0.70
14.29%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.11
-0.39
71.79%
Operating Profit Margin (Excl OI)
11.54%
9.31%
2.23%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 14.97% vs -21.54% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 71.79% vs -169.64% in Mar 2024

stock-summaryCompany CV
About Chemiesynth (Vapi) Ltd stock-summary
stock-summary
Chemiesynth (Vapi) Ltd
Micro Cap
Specialty Chemicals
Chemiesynth (Vapi) Ltd. was incorporated in April, 1986. Company is a custom manufacturing for leading Agro chemical, Pharmaceutical and Specialty Chemical Companies. With over 30 years of experience in synthesis of organic chemicals, Chemiesynth Group has established itself as an innovative player in custom manufacturing. The key product markets include agro chemicals, pharmaceutical, photographic and cosmetics.
Company Coordinates stock-summary
Company Details
27 GIDC, 1st Phase VAPI Gujarat : 396195
stock-summary
Tel: 91-260-2432885
stock-summary
corporate@chemiesynth.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai